Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y

被引：703

作者：

Pavel, M. ^{[1
]}

Oberg, K. ^{[2
]}

Falconi, M. ^{[3
]}

Krenning, E. P. ^{[4
]}

Sundin, A. ^{[5
]}

Perren, A. ^{[6
]}

Berruti, A. ^{[7
]}

机构：

[1] Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany

[2] Uppsala Univ, Dept Endocrine Oncol, Uppsala, Sweden

[3] IRCCS San Raffaele Sci Inst, Dept Surg, Milan, Italy

[4] Cyclotron Rotterdam BV, Erasmus Med Ctr, Rotterdam, Netherlands

[5] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden

[6] Univ Bern, Inst Pathol, Bern, Switzerland

[7] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, ASST Spedali Civili, Brescia, Italy

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 07期

关键词：

RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; LIVER METASTASES; OCTREOTIDE-LAR; PHASE-III; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; GASTROINTESTINAL-TRACT; TYR(3) OCTREOTATE; ENDOCRINE TUMORS; DOUBLE-BLIND;

D O I：

10.1016/j.annonc.2020.03.304

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：844 / 860

页数：17

共 106 条

[81] Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Rinke, Anja
Mueller, Hans-Helge
Schade-Brittinger, Carmen
Klose, Klaus-Jochen
Barth, Peter
Wied, Matthias
Mayer, Christina
Aminossadati, Behnaz
Pape, Ulrich-Frank
Blaeker, Michael
Harder, Jan
Arnold, Christian
Gress, Thomas
Arnold, Rudolf
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4656 - 4663
[82] Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases
Ronot, Maxime
Clift, Ashley K.
Baum, Richard P.
Singh, Aviral
Kulkarni, Harshad R.
Frilling, Andrea
Vilgrain, Valerie
[J]. NEUROENDOCRINOLOGY, 2018, 106 (01) : 74 - 88
[83] Whole-genome landscape of pancreatic neuroendocrine tumours
Scarpa, Aldo
Chang, David K.
Nones, Katia
Corbo, Vincenzo
Patch, Ann-Marie
Bailey, Peter
Lawlor, Rita T.
Johns, Amber L.
Miller, David K.
Mafficini, Andrea
Rusev, Borislav
Scardoni, Maria
Antonello, Davide
Barbi, Stefano
Sikora, Katarzyna O.
Cingarlini, Sara
Vicentini, Caterina
McKay, Skye
Quinn, Michael C. J.
Bruxner, Timothy J. C.
Christ, Angelika N.
Harliwong, Ivon
Idrisoglu, Senel
McLean, Suzanne
Nourse, Craig
Nourbakhsh, Ehsan
Wilson, Peter J.
Anderson, Matthew J.
Fink, J. Lynn
Newell, Felicity
Waddell, Nick
Holmes, Oliver
Kazakoff, Stephen H.
Leonard, Conrad
Wood, Scott
Xu, Qinying
Nagaraj, Shivashankar Hiriyur
Amato, Eliana
Dalai, Irene
Bersanif, Samantha
Cataldo, Ivana
Tos, Angelo P. Dei
Capelli, Paola
Davi, Maria Vittoria
Landoni, Luca
Malpaga, Anna
Miotto, Marco
Whitehall, Vicki L. J.
Leggett, Barbara A.
Harris, Janelle L.
[J]. NATURE, 2017, 543 (7643) : 65 - +
[84] Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas
Schmid-Tannwald, Christine
Schmid-Tannwald, Christoph M.
Morelli, John N.
Neumann, Ralph
Haug, Alexander R.
Jansen, Nathalie
Nikolaou, Konstantin
Schramm, Nicolai
Reiser, Maximilian F.
Rist, Carsten
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) : 897 - 907
[85] Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
Severi, Stefano
Grassi, Ilaria
Nicolini, Silvia
Sansovini, Maddalena
Bongiovanni, Alberto
Paganelli, Giovanni
[J]. ONCOTARGETS AND THERAPY, 2017, 10 : 551 - 557
[86] Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
Simsek, Duygu Has
Kuyumcu, Serkan
Turkmen, Cuneyt
Sanli, Yasemin
Aykan, Faruk
Unal, Seher
Adalet, Isik
[J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) : 1811 - 1817
[87] Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
Singh, Simron
Carnaghi, Carlo
Buzzoni, Roberto
Pommier, Rodney F.
Raderer, Markus
Tomasek, Jiri
Lahner, Harald
Valle, Juan W.
Voi, Maurizio
Bubuteishvili-Pacaud, Lida
Lincy, Jeremie
Wolin, Edward
Okita, Natsuko
Libutti, Steven K.
Oh, Do-Youn
Kulke, Matthew
Strosberg, Jonathan
Yao, James C.
Pavel, Marianne E.
Fazio, Nicola
[J]. NEUROENDOCRINOLOGY, 2018, 106 (03) : 211 - 220
[88] Gastroenteropancreatic High-Grade Neuroendocrine Carcinoma
Sorbye, Halfdan
Strosberg, Jonathan
Baudin, Eric
Klimstra, David S.
Yao, James C.
[J]. CANCER, 2014, 120 (18) : 2814 - 2823
[89] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J.
El-Haddad, G.
Wolin, E.
Hendifar, A.
Yao, J.
Chasen, B.
Mittra, E.
Kunz, P. L.
Kulke, M. H.
Jacene, H.
Bushnell, D.
O'Dorisio, T. M.
Baum, R. P.
Kulkarni, H. R.
Caplin, M.
Lebtahi, R.
Hobday, T.
Delpassand, E.
Van Cutsem, E.
Benson, A.
Srirajaskanthan, R.
Pavel, M.
Mora, J.
Berlin, J.
Grande, E.
Reed, N.
Seregni, E.
Oberg, K.
Sierra, M. Lopera
Santoro, P.
Thevenet, T.
Erion, J. L.
Ruszniewski, P.
Kwekkeboom, D.
Krenning, E.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02) : 125 - 135
[90] Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Strosberg, Jonathan
Wolin, Edward
Chasen, Beth
Kulke, Matthew
Bushnell, David
Caplin, Martyn
Baum, Richard P.
Kunz, Pamela
Hobday, Timothy
Hendifar, Andrew
Oberg, Kjell
Sierra, Maribel Lopera
Thevenet, Thomas
Margalet, Ines
Ruszniewski, Philippe
Krenning, Eric
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (25) : 2578 - +

← 2 3 4 5 6 7 8 9 10 11 →